[DPHARMA] QoQ Cumulative Quarter Result on 30-Sep-2015 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
24-Nov-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
30-Sep-2015 [#3]
Profit Trend
QoQ- 58.2%
YoY- -4.62%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 158,605 79,470 270,680 181,279 101,907 45,599 176,961 -7.04%
PBT 17,664 9,941 49,755 32,226 20,605 12,198 46,509 -47.58%
Tax -5,895 -2,113 0 -8,786 -5,788 -3,229 0 -
NP 11,769 7,828 49,755 23,440 14,817 8,969 46,509 -60.02%
-
NP to SH 12,346 7,843 38,775 23,440 14,817 8,969 35,271 -50.36%
-
Tax Rate 33.37% 21.26% 0.00% 27.26% 28.09% 26.47% 0.00% -
Total Cost 146,836 71,642 220,925 157,839 87,090 36,630 130,452 8.21%
-
Net Worth 446,334 457,492 270,177 268,509 190,284 205,045 192,942 75.00%
Dividend
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Div 6,973 - 15,843 - 5,596 - 25,679 -58.09%
Div Payout % 56.49% - 40.86% - 37.77% - 72.81% -
Equity
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Net Worth 446,334 457,492 270,177 268,509 190,284 205,045 192,942 75.00%
NOSH 278,959 278,959 278,959 278,959 139,915 139,486 138,807 59.32%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin 7.42% 9.85% 18.38% 12.93% 14.54% 19.67% 26.28% -
ROE 2.77% 1.71% 14.35% 8.73% 7.79% 4.37% 18.28% -
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 56.86 28.49 162.30 108.70 72.83 32.69 127.49 -41.65%
EPS 4.22 2.81 19.17 14.04 10.59 6.43 25.41 -69.81%
DPS 2.50 0.00 9.50 0.00 4.00 0.00 18.50 -73.69%
NAPS 1.60 1.64 1.62 1.61 1.36 1.47 1.39 9.84%
Adjusted Per Share Value based on latest NOSH - 278,959
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
RPS 16.49 8.26 28.14 18.85 10.59 4.74 18.40 -7.05%
EPS 1.28 0.82 4.03 2.44 1.54 0.93 3.67 -50.48%
DPS 0.72 0.00 1.65 0.00 0.58 0.00 2.67 -58.29%
NAPS 0.464 0.4756 0.2809 0.2791 0.1978 0.2132 0.2006 74.99%
Price Multiplier on Financial Quarter End Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 -
Price 2.04 2.55 2.62 2.72 2.65 3.88 2.50 -
P/RPS 3.59 8.95 1.61 2.50 3.64 11.87 1.96 49.75%
P/EPS 46.09 90.70 11.27 19.35 25.02 60.34 9.84 180.20%
EY 2.17 1.10 8.87 5.17 4.00 1.66 10.16 -64.30%
DY 1.23 0.00 3.63 0.00 1.51 0.00 7.40 -69.80%
P/NAPS 1.28 1.55 1.62 1.69 1.95 2.64 1.80 -20.34%
Price Multiplier on Announcement Date
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Date 22/08/16 18/05/16 23/02/16 24/11/15 25/08/15 18/05/15 24/02/15 -
Price 2.14 2.40 2.61 2.70 2.40 3.90 2.92 -
P/RPS 3.76 8.42 1.61 2.48 3.30 11.93 2.29 39.21%
P/EPS 48.35 85.36 11.23 19.21 22.66 60.65 11.49 160.87%
EY 2.07 1.17 8.91 5.21 4.41 1.65 8.70 -61.63%
DY 1.17 0.00 3.64 0.00 1.67 0.00 6.34 -67.61%
P/NAPS 1.34 1.46 1.61 1.68 1.76 2.65 2.10 -25.90%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment